Nipro Renal Soultions USA, Corporation recalls MedicaLyte Liquid Bicarbonate Concentrate REF: BC-100 and BC+201
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Hemodialysis concentrates contain high endotoxin levels
- Products
-
- MedicaLyte Liquid Bicarbonate Concentrate REF: BC-100 and BC+201
- Where it was sold
-
Worldwide - US Nationwide distribution in the states of FL, GA, IL, MD, MI, NC, NJ, NV, OH, PA, and the countries of Guatemala and Panama.
States: Florida, Georgia, Illinois, Maryland, Michigan, North Carolina, New Jersey, Nevada, Ohio, Pennsylvania
- Units affected
- 3,286 cases
- About this recall
- MedicaLyte Liquid Bicarbonate Concentrate REF: BC-100 and BC+201